MariMed (OTC:MRMD) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $39.481 million which beat the analyst consensus estimate of $38.750 million by 1.89 percent. This is a 4.02 percent increase over sales of $37.955 million the same period last year.